Product Code: LFN FDA class 2 21 CFR 862.3660

Nephelometric Inhibition Immunoassay, Phenobarbital

Clinical Toxicology

A nephelometric inhibition immunoassay for phenobarbital is a laboratory test that uses light-scattering measurement principles to quantify phenobarbital concentrations in patient specimens, supporting therapeutic drug monitoring in patients on anticonvulsant therapy. The device is FDA Class 2, indicating moderate risk and requiring 510(k) premarket notification. It carries product code LFN and is regulated under 21 CFR 862.3660 within the Clinical Toxicology specialty. This device is eligible for third-party review.

510(k)s
5
FEI Numbers
2
Registration Numbers
2
Unique Applicants
4
Years Active
12

Basic Information

Product Code
LFN
Device Class
FDA class 2
Regulation Number
862.3660
Medical Specialty
Clinical Toxicology
Review Panel
TX
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 5 510(k) clearances via K numbers.

K Number Device Name
K934388 QMS PHENOBARBITAL
K864612 DART PHENOBARBITAL ASSAY SYSTEM
K860304 DUPONT PHENOBARBITAL ASSAY
K860303 DUPONT PHENOBARBITAL CALIBRATOR
K821543 IPA FOR DETECTION OF PHENOBARBITAL

FEI Numbers

This FDA classification entry is associated with 2 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 2 registration numbers. Click on an entry to view related FDA registrations.